191 related articles for article (PubMed ID: 27604323)
21. Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays.
Bian X; Wallstrom G; Davis A; Wang J; Park J; Throop A; Steel J; Yu X; Wasserfall C; Schatz D; Atkinson M; Qiu J; LaBaer J
Diabetes; 2016 Jan; 65(1):285-96. PubMed ID: 26450993
[TBL] [Abstract][Full Text] [Related]
22. Is juvenile diabetes a viral disease?
Fohlman J; Friman G
Ann Med; 1993 Dec; 25(6):569-74. PubMed ID: 8292308
[TBL] [Abstract][Full Text] [Related]
23. Type 1 diabetes and Coxsackie virus infection.
Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
[TBL] [Abstract][Full Text] [Related]
24. Viral infection of engrafted human islets leads to diabetes.
Gallagher GR; Brehm MA; Finberg RW; Barton BA; Shultz LD; Greiner DL; Bortell R; Wang JP
Diabetes; 2015 Apr; 64(4):1358-69. PubMed ID: 25392246
[TBL] [Abstract][Full Text] [Related]
25. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes.
Varela-Calvino R; Ellis R; Sgarbi G; Dayan CM; Peakman M
Diabetes; 2002 Jun; 51(6):1745-53. PubMed ID: 12031961
[TBL] [Abstract][Full Text] [Related]
27. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.
Bonifacio E; Ziegler AG; Klingensmith G; Schober E; Bingley PJ; Rottenkolber M; Theil A; Eugster A; Puff R; Peplow C; Buettner F; Lange K; Hasford J; Achenbach P;
JAMA; 2015 Apr; 313(15):1541-9. PubMed ID: 25898052
[TBL] [Abstract][Full Text] [Related]
28. [Anti-Coxsakie B viruses humoral immunity status in patients with pancreatic diseases].
Trukhan DI
Vopr Virusol; 2001; 46(2):33-6. PubMed ID: 11392968
[TBL] [Abstract][Full Text] [Related]
29. An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response.
Friman G; Fohlman J; Frisk G; Diderholm H; Ewald U; Kobbah M; Tuvemo T
Acta Paediatr Scand Suppl; 1985; 320():14-9. PubMed ID: 3010631
[TBL] [Abstract][Full Text] [Related]
30. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B.
Hyöty H; Leon F; Knip M
Expert Rev Vaccines; 2018 Dec; 17(12):1071-1083. PubMed ID: 30449209
[TBL] [Abstract][Full Text] [Related]
31. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis.
Foulis AK; Farquharson MA; Cameron SO; McGill M; Schönke H; Kandolf R
Diabetologia; 1990 May; 33(5):290-8. PubMed ID: 2376300
[TBL] [Abstract][Full Text] [Related]
32. Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes.
Laitinen OH; Honkanen H; Pakkanen O; Oikarinen S; Hankaniemi MM; Huhtala H; Ruokoranta T; Lecouturier V; André P; Harju R; Virtanen SM; Lehtonen J; Almond JW; Simell T; Simell O; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetes; 2014 Feb; 63(2):446-55. PubMed ID: 23974921
[TBL] [Abstract][Full Text] [Related]
33. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection.
Chehadeh W; Weill J; Vantyghem MC; Alm G; Lefèbvre J; Wattré P; Hober D
J Infect Dis; 2000 Jun; 181(6):1929-39. PubMed ID: 10837172
[TBL] [Abstract][Full Text] [Related]
34. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus].
Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O
Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989
[TBL] [Abstract][Full Text] [Related]
35. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency.
Tuvemo T; Dahlquist G; Frisk G; Blom L; Friman G; Landin-Olsson M; Diderholm H
Diabetologia; 1989 Oct; 32(10):745-7. PubMed ID: 2556308
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiologic factors and serum antibody titer to Coxsackie B-4 virus in patients with type I diabetes].
Tuszkiewicz-Misztal E
Kinderarztl Prax; 1991 Mar; 59(3):88-91. PubMed ID: 1647469
[TBL] [Abstract][Full Text] [Related]
37. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes.
Skarsvik S; Puranen J; Honkanen J; Roivainen M; Ilonen J; Holmberg H; Ludvigsson J; Vaarala O
Diabetes; 2006 Apr; 55(4):996-1003. PubMed ID: 16567521
[TBL] [Abstract][Full Text] [Related]
38. Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
Ronkainen MS; Hoppu S; Korhonen S; Simell S; Veijola R; Ilonen J; Simell O; Knip M
Eur J Endocrinol; 2006 Oct; 155(4):633-42. PubMed ID: 16990664
[TBL] [Abstract][Full Text] [Related]
39. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.
Vreugdenhil GR; Schloot NC; Hoorens A; Rongen C; Pipeleers DG; Melchers WJ; Roep BO; Galama JM
Clin Infect Dis; 2000 Oct; 31(4):1025-31. PubMed ID: 11049787
[TBL] [Abstract][Full Text] [Related]
40. Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes.
Surcel HM; Ilonen J; Käär ML; Hyöty H; Leinikki P
Acta Paediatr Scand; 1988 May; 77(3):471-4. PubMed ID: 2839003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
